Development of Novel NPC1-Targeting Autophagy Inhibitors for the Treatment of Uveal Melanoma
Background: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults, and up to 50% of patients develop liver metastases. Metastatic
Background: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults, and up to 50% of patients develop liver metastases. Metastatic